“SOCIODEMOGRAPHIC, CLINICAL CHARACTERISTICS & COMPLICATIONS AMONG ONCOLOGICAL PATIENTS WITH CHEMOPORTS & REASONS FOR REMOVAL OF CHEMOPORTS: AN OBSERVATIONAL STUDY IN A TERTIARY CARE CENTRE IN WESTERN RAJASTHAN”
Main Article Content
Keywords
Chemoport, Chemotherapy, oncological diagnosis, stable venous access, venipuncture
Abstract
: The management of a cancer patient demands stable venous access that can be utilized for giving chemotherapy, administering blood products, antibiotics and fluid replacement therapy. The use of long-term venous access devices or central venous catheters can also alleviate patient anxiety associated with repeated venipunctures. Chemo ports, also known as implantable ports or venous access devices, have become an increasingly common solution to facilitate chemotherapy administration. These devices have become the cornerstone of modern medical therapy in oncological practice.Material and method: This observational study was performed on 100 patients of various oncological diagnosis who underwent chemoport insertion for purpose of chemotherapy delivery in surgical departments of DR.S.N. Medical College, Jodhpur from May 2022 to October 2024.
Result: Most common age group pf patients was 40-60 years with a female predominance & breast cancer as the most common oncological diagnosis in patients who underwent chemoport insertion in our study. The mean duration of port in situ was 382.5 days. Complications are significantly varied, with septic complications being the most common, followed by thrombosis. Most of the complications were managed by removal of chemoport and some being managed conservatively. All the studied parameters were comparable with previous studies.
Conclusion: This study meticulously examines the complications associated with chemoports, including infections, thrombosis, mechanical issues, and port-related pain, documenting their incidence and severity. The study also underscores the critical role of chemoports in oncological care, highlighting their effectiveness in reducing the necessity for multiple painful venipunctures to administer chemotherapeutic agents by minimizing the pain and anxiety associated with cancer treatment & significantly enhancing the quality of life.
References
2. Chu FS, Cheng VC, Law MW, Tso WK. Efficacy and complications in peripherally inserted central catheter insertion: a study using 4-Fr nonvalved catheters and a single infusate. Australas Radiol. 2007;51:453–457.
3. Yap S, Karapetis C, Lerose S, Iyer S, Koczwara B. Reducing the risk of peripherally inserted central catheter line complications in the oncology setting. Eur J Cancer Care (Engl). 2006;15:342–347.
4. Ahn SJ, Kim HC, Chung JW, et al. Ultrasound and fluoroscopy-guided placement of central venous ports via internal jugular vein: retrospective analysis of 1254 port implantations at a single center. Korean J Radiol. 2012;13:314–323.
5. McCready D, Broadwater R, Ross M, Pollock R, Ota D, Balch C. A case-control comparison of durability and cost between implanted reservoir and percutaneous catheters in cancer patients. J Surg Res. 1991;51:377–381.
6. Salem R, Ward B, Ravikumar TS. A new peripherally implanted subcutaneous permanent central venous access device for patients requiring chemotherapy. J Clin Oncol. 1993;11:2181–2185.
7. Jain SA, Shukla SN, Talati SS, et al. A retrospective study of central venous catheters GCRI experience. Indian J Med Paediatr Oncol. 2013;34(1):238–241.
8. Abraham SW, Bassi KK, Giri AK, Pandey KK, Pattanayak M. Totally implant- able venous access ports: retrospective review of long-term complications in 81 patients. Indian J Cancer. 2012;49(5):114–118.
9. Aparna S, Ramesh S, Appaji L, et al. Complications of chemoport in children with cancer: experience of 54,100 catheter days from a tertiary cancer center of Southern India. South Asian J Cancer. 2015;4(2):143–145.
10. Kock HJ, Pietsch M, Krause U, Wilke H, Eigler FW. Implantable vascular access system: experience in 1500 patients with totally implanted central venous port systems. World J Surg. 1998;22(5):12–16.
11. Fang S, Yang J, Song L, Jiang Y, Liu Y. Comparison of three types of central venous catheters in patients with malignant tumor receiving chemotherapy. Patient Prefer Adherence. 2017 Jul 12;11:1197-1204. doi: 10.2147/PPA.S142556. PMID: 28744109; PMCID: PMC5513891.
Article Sidebar
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
All articles published in JPTCP are licensed under Copyright Creative Commons Attribution-NonCommercial 4.0 International License.
Suresh Kumar
Post Graduate Student,
Ram Dayal
Assistant professor,
Vijay Verma
Professor Department of Surgery, Dr. S.N. Medical College, Jodhpur, Raj ,
Sunita Malviya
Post Graduate Student.
Kishna Ram
Post Graduate Student.